backgroundvir
respiratori
infect
among
common
reason
hospit
children
unit
state
object
compar
molecular
convent
method
cohort
hospit
children
without
symptom
respiratori
viral
ill
rvi
hospit
patient
visit
test
admiss
convent
test
immunochromatographi
direct
fluoresc
antibodi
shell
vial
tube
cultur
perform
patient
nucleic
acid
test
nat
perform
avail
sampl
virus
group
routin
group
routin
group
detect
convent
method
resultsin
children
rvi
symptom
nat
identifi
viru
specimen
compar
convent
method
p
detect
similar
percentag
specimen
group
virus
compar
convent
test
children
without
rvi
symptom
nat
identifi
viru
specimen
compar
convent
test
p
identifi
group
virus
compar
convent
test
group
virus
identifi
nat
similar
percentag
symptomat
asymptomat
patient
conclusionmolecular
assay
may
sever
advantag
convent
method
detect
respiratori
virus
includ
improv
sensit
rapid
detect
given
high
preval
posit
result
children
without
rvi
symptom
result
interpret
cautious
viral
respiratori
infect
among
common
reason
emerg
depart
visit
hospit
children
unit
state
econom
impact
viral
respiratori
infect
estim
around
billion
cohort
studi
identifi
children
respiratori
viral
ill
reli
test
children
common
clinic
symptom
fever
rhinorrhea
cough
rapid
detect
respiratori
virus
guid
antivir
therapi
limit
diagnost
test
invas
costli
facilit
cohort
patient
prevent
nosocomi
transmiss
current
challeng
detect
respiratori
virus
includ
inconsist
clinic
manifest
respiratori
viral
ill
variabl
sensit
specif
avail
diagnost
assay
tradit
method
diagnos
respiratori
virus
includ
direct
fluoresc
antibodi
dfa
enzym
immunoassay
eia
provid
result
within
hour
limit
scope
sensit
posit
predict
valu
viral
cultur
specif
time
consum
technic
demand
new
molecular
techniqu
detect
respiratori
virus
gain
popular
compar
tradit
method
polymeras
chain
reaction
pcr
nucleic
acid
test
nat
increas
sensit
detect
common
respiratori
virus
rhinoviru
enteroviru
well
identifi
emerg
virus
includ
human
metapneumoviru
hmpv
coronaviru
bocaviru
molecular
laboratori
techniqu
becom
widespread
potenti
detect
wide
rang
establish
newli
discov
virus
howev
interpret
posit
result
must
made
cautious
context
patient
clinic
ill
posit
result
may
signifi
presenc
viru
necessarili
indic
viru
caus
patient
clinic
symptom
object
compar
result
molecular
techniqu
convent
diagnost
method
cohort
hospit
children
without
symptom
respiratori
viral
ill
rvi
children
admit
infant
toddler
ward
within
hour
hospit
john
hopkin
hospit
children
center
decemb
march
includ
studi
infant
toddler
ward
care
primarili
children
three
year
age
younger
wide
rang
underli
medic
issu
john
hopkin
hospit
comprehens
program
identifi
isol
children
contagi
respiratori
virus
begin
patient
admit
infant
toddler
ward
nasopharyng
aspir
npa
collect
within
hour
admiss
regardless
presenc
respiratori
symptom
part
standard
care
complet
medic
record
obtain
children
npa
sampl
collect
categor
patient
present
rvi
symptom
exhibit
upperlow
respiratori
tract
symptom
consist
respiratori
viral
ill
eg
rhinorrhea
congest
cough
apnea
wheez
tachypnea
hypoxia
subtl
symptom
like
unexplain
fever
time
admiss
within
day
hospit
without
rvi
symptom
symptom
consist
respiratori
viral
ill
time
admiss
within
day
hospit
studi
approv
john
hopkin
school
medicin
institut
review
board
waiver
inform
consent
npa
specimen
test
use
convent
method
residu
specimen
store
celsiu
identifi
nat
figur
supplement
digit
content
http
illustr
number
patient
admiss
npa
collect
residu
specimen
avail
test
patient
without
residu
specimen
compar
virus
group
routin
routin
detect
convent
method
group
adenoviru
influenza
flu
respiratori
syncyti
viru
rsv
parainfluenza
piv
group
hmpv
rhinoviru
enteroviru
coronaviru
convent
diagnost
methodsnpa
initi
test
use
immunochromatographi
identifi
rsv
flu
flu
b
previous
describ
neg
specimen
test
dfa
stain
shell
vial
cultur
tube
cultur
identifi
rsv
flu
flu
b
piv
adenoviru
hmpv
see
b
molecular
diagnost
methodsavail
specimen
test
nat
describ
result
obtain
two
nat
discord
specimen
test
third
nat
except
rhinovirus
enterovirus
discuss
confirm
molecular
result
requir
viru
detect
two
nat
resplexii
panel
qiagen
germantown
md
provid
differenti
detect
viral
gene
target
use
qiaplex
xmap
technolog
viral
target
detect
rsv
b
flu
b
piv
hmpv
coxsackievirus
echovirus
rhinoviru
adenoviru
b
e
coronavirus
oc
bocaviru
resplexii
panel
amplif
detect
perform
per
manufactur
instruct
softwar
defin
cutoff
posit
sever
studi
use
varieti
cutoff
valu
analysi
studi
resplexii
result
initi
analyz
use
four
cutoff
valuesthre
time
background
mfi
valu
three
time
background
cutoff
select
demonstr
excel
overal
agreement
method
allow
interrun
data
normal
account
runtorun
variabl
background
fluoresc
purpos
studi
flu
b
differenti
coronavirus
combin
due
small
number
also
rsv
b
differenti
bocaviru
includ
analysi
bocavirus
detect
resplexii
detect
reagent
initi
avail
rvsm
panel
drop
product
cours
studi
due
chang
rvsm
product
unresolv
diagnost
util
bocaviru
test
elect
perform
analysi
bocaviru
detect
resplexii
respiratori
viru
surveil
kit
electrospray
ioniz
mass
spectrometri
rvsm
rvsm
ibi
bioscienc
inc
part
abbott
molecular
de
plain
il
detect
rsv
flu
b
piv
hmpv
adenovirus
af
coronavirus
amplif
product
analyz
use
univers
biosensor
mass
measur
complimentari
singlestrand
determin
nucleotid
composit
compar
known
databas
establish
viru
identif
c
addit
molecular
diagnost
methodstwo
individu
realtim
revers
transcriptas
pcr
rtpcr
assay
enterovirus
rhinovirus
use
compar
resplexii
virus
detect
rvsm
discord
result
enterovirus
rhinovirus
perform
use
third
nat
discord
result
resplex
ii
rvsm
adenoviru
hmpv
adjud
use
realtim
pcr
xtag
respiratori
viral
panel
rvp
luminex
austin
texa
use
adjud
discrep
resplexii
rvsm
rsv
data
maintain
microsoft
access
microsoft
bellevu
wa
analyz
use
stata
version
stata
corp
colleg
station
tx
demograph
clinic
variabl
describ
frequenc
percent
median
interquartil
rang
iqr
use
two
sampl
test
proport
compar
characterist
patient
without
residu
specimen
well
compar
posit
result
molecular
convent
test
twotail
pvalu
consid
statist
signific
cohort
patient
visit
underw
npa
test
admiss
children
test
patient
admit
rvi
symptom
convent
test
method
detect
respiratori
viru
children
includ
symptom
rvi
without
symptom
rvi
test
convent
method
specimen
avail
molecular
test
compar
without
residu
specimen
found
group
similar
regard
demograph
characterist
patient
residu
sampl
like
viru
detect
convent
test
compar
without
residu
sampl
vs
p
tabl
group
without
residu
specimen
equal
like
rvi
symptom
vs
residu
specimen
test
posit
nat
posit
convent
test
p
tabl
children
rvi
symptom
nat
identifi
viru
compar
convent
method
p
tabl
increas
detect
larg
due
patient
identifi
group
viru
detect
convent
method
convent
molecular
assay
detect
similar
percent
patient
group
virus
v
howev
compar
posit
result
nat
convent
test
provid
result
within
hour
eia
dfa
shell
vial
cultur
nat
increas
viru
detect
v
children
without
rvi
symptom
nat
identifi
viru
compar
convent
method
p
similar
patient
rvi
symptom
increas
detect
larg
due
patient
identifi
group
viru
nat
also
identifi
group
virus
compar
convent
test
patient
v
preval
group
viru
asymptomat
patient
rhinoviru
enteroviru
detect
specimen
resplexii
group
virus
identifi
nat
similar
percentag
symptomat
asymptomat
patient
children
rvi
symptom
tabl
neither
resplexii
rvsm
detect
significantli
higher
percentag
group
virus
convent
test
respect
addit
posit
result
rvsm
detect
adenoviru
howev
specimen
confirm
adenoviru
nat
similarli
addit
posit
result
resplexii
mostli
detect
hmpv
case
sampl
posit
hmpv
resplexii
confirm
two
molecular
nat
children
without
rvi
symptom
tabl
rvsm
detect
higher
percentag
group
virus
compar
convent
test
addit
posit
result
rvsm
detect
adenoviru
case
sampl
posit
adenoviru
rvsm
confirm
second
molecular
assay
children
avail
specimen
molecular
test
detect
singl
viru
specimen
specimen
reveal
coinfect
one
viru
virus
detect
remain
specimen
convent
test
detect
coinfect
cohort
coinfect
rhinoviru
identifi
specimen
greater
proport
viral
coinfect
present
rvi
symptom
vs
p
result
demonstr
nat
increas
rapid
detect
respiratori
virus
symptomat
patient
also
uncov
high
preval
posit
test
result
respiratori
virus
children
without
rvi
symptom
molecular
assay
sever
advantag
convent
method
detect
respiratori
virus
includ
improv
sensit
rel
rapid
result
autom
process
result
interpret
cautious
particularli
clinic
symptom
suggest
rvi
casecontrol
studi
past
detect
respiratori
virus
asymptomat
children
knowledg
first
cohort
studi
compar
result
multipl
molecular
assay
convent
test
infant
toddler
without
rvi
symptom
cohort
molecular
test
identifi
respiratori
viru
patient
inclus
children
present
without
symptom
rvi
may
explain
lower
detect
rate
previous
report
respiratori
virus
use
molecular
assay
children
rvi
symptom
nat
identifi
respiratori
viru
npa
specimen
compar
convent
test
previou
studi
children
acut
respiratori
viral
ill
nasal
aspir
found
posit
molecular
nat
compar
convent
method
cohort
molecular
test
increas
overal
detect
group
virus
compar
convent
test
children
rvi
symptom
increas
sensit
convent
test
may
attribut
use
tube
cultur
viru
detect
laboratori
howev
compar
result
convent
test
avail
within
hour
increas
detect
group
virus
nat
find
confirm
previou
report
molecular
test
increas
rapid
identif
convent
virus
like
rsv
influenza
piv
adenovirus
patient
respiratori
ill
children
without
rvi
symptom
nat
identifi
respiratori
viru
npa
specimen
compar
convent
test
although
nat
increas
detect
group
virus
compar
convent
test
children
major
virus
identifi
children
without
rvi
symptom
group
virus
includ
rhinoviru
enteroviru
coronaviru
hmpv
interestingli
molecular
assay
detect
almost
equal
percentag
group
virus
symptomat
asymptomat
children
suggest
virus
may
commonli
present
respiratori
tract
young
children
shown
previous
rhinoviru
cohort
almost
half
npa
specimen
posit
rhinovirusenteroviru
obtain
children
without
rvi
symptom
rhinoviru
detect
asymptomat
children
shown
persist
case
week
beyond
acut
infect
find
bring
light
import
strength
challeng
nat
confirm
prior
report
molecular
test
increas
sensit
rapid
detect
compar
tradit
method
howev
increas
sensit
may
alway
improv
clinic
outcom
influenc
clinician
behavior
random
trial
studi
impact
viral
test
patient
manag
bonner
et
al
show
differ
manag
children
respiratori
viral
ill
except
influenza
anoth
random
trial
influenza
rapid
test
show
use
rapid
test
influenc
clinician
behavior
molecular
test
increas
detect
group
virus
like
rhinoviru
enteroviru
absenc
avail
therapeut
unless
posit
test
limit
antibiot
usag
diagnost
test
test
result
may
chang
cours
treatment
improv
patient
outcom
recent
research
suggest
may
associ
rhinoviru
induc
wheez
childhood
asthma
role
avail
antivir
therapi
children
remain
question
rapid
detect
respiratori
virus
use
isol
contagi
patient
prevent
transmiss
virus
hospit
patient
increas
detect
pcr
posit
cultur
neg
patient
may
neg
consequ
unnecessari
isol
hospit
patient
studi
need
assess
impact
diagnost
test
patient
outcom
clinic
lab
begin
use
molecular
test
detect
respiratori
virus
sever
point
worth
note
regard
data
first
analysi
patient
without
residu
specimen
demonstr
residu
specimen
like
posit
convent
test
result
howev
group
without
avail
specimen
otherwis
similar
equal
proport
children
rvi
symptom
studi
popul
find
reflect
entir
cohort
second
standard
method
detect
respiratori
virus
nat
fals
posit
compar
result
larg
multiplex
nat
found
overal
good
concord
nat
discord
use
third
molecular
assay
singleplex
rtpcr
xtag
rvp
confirm
result
also
resplexii
demonstr
cross
reactiv
detect
rhinoviru
enteroviru
henc
posit
result
report
combin
rhinovirusenteroviru
final
singl
institut
studi
hospit
patient
find
may
generaliz
institut
set
gener
advantag
disadvantag
molecular
test
still
like
remain
result
studi
confirm
previou
report
molecular
test
increas
detect
respiratori
virus
children
respiratori
ill
also
detect
virus
mani
children
without
rvi
symptom
detect
respiratori
virus
asymptomat
children
common
pose
challeng
diagnost
interpret
molecular
nat
studi
focu
defin
cutoff
valu
aid
interpret
posit
result
accuraci
reliabl
clinician
encourag
interpret
result
base
variat
patient
popul
characterist
clinic
present
season
occurr
local
viru
epidemiolog
care
interpret
test
result
need
make
complic
decis
guid
individu
patient
treatment
manag
tabl
characterist
patient
without
residu
specimen
avail
molecular
test
